G-protein coupled estrogen receptor 1 expression in rat and human heart: Protective role during ischaemic stress

International Journal of Molecular Medicine

Volumn 26, Issue 2, 2010, Pages 193-199

  Patel, Vanlata H ^a   Chen, Jing ^a   Ramanjaneya, Manjunath ^a   Karteris, Emmanouil ^b   Zachariades, Elena ^b   Thomas, Peter ^c   Been, Martin ^a   Randeva, Harpal S ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Cardiac ischaemia; Cardioprotection; G protein coupled estrogen receptor 1; G1; Hypoxia

Indexed keywords

COMPLEMENTARY DNA; ESTRADIOL; ESTROGEN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 1; G PROTEIN COUPLED RECEPTOR 30; MESSENGER RNA; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; GPER PROTEIN, HUMAN; GPR30 PROTEIN, RAT; PROTECTIVE AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART STRESS; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; ANALYSIS OF VARIANCE; ANIMAL; CYTOCHEMISTRY; GENE EXPRESSION; GENETICS; HEART VENTRICLE PRESSURE; MALE; METABOLISM; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; GENE EXPRESSION; HISTOCYTOCHEMISTRY; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PROTECTIVE AGENTS; RATS; RATS, WISTAR; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VENTRICULAR PRESSURE;

EID: 77955727649     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000452     Document Type: Article

References (37)

1. Chaudhuri G: Nuclear receptors and female reproduction: a tale of 3 scientists, Jensen, Gustafsson and O'Malley: Reprod Sci 15: 110-120, 2008.
2. Barret-Connor E: Sex differences in coronary heart disease: Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95: 252-264, 1997
3. Crabbe DL, Dipla K, Ambati S, Zafeiridis A, Gaughan, JP, Houser SR and Margulies KB: Gender differences in post-infarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol 41: 300-306, 2003. (Pubitemid 36092201)
4. Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM and Gross DR: Effects of estrogen on global myocardial ischaemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 279: 2766-2775, 2000.
5. Xu Y, Arenas IA, Armstrong SJ, Plahta WC, Sandra HX and Davigge ST: Estrogen cardiac recovery after ischaemia/reperfusion by decreasing tumour necrosis factor-alpha. Cardiovasc Res 69: 777-780, 2006.
6. Beer S, Reincke M, Kral M, Callies F, Stromer H, Dienesch C, Steinhauer S, Ertl G, Allolio B and Neubauer S: High dose 17 beta estradiol treatment prevents development of heart failure post-myocardial infarction in the rat. Basic Res Cardiol 102: 9-18, 2007.
7. Wang T, Tsai BM, Reiger KM, Brown JW and Meldrum DR: 17 beta-estradiol decreases p38 MAPK-medited myocardial inflammation and dysfunction following acute ischemia. J Mol Cell Cardiol 40: 205-212, 2006.
8. + channels in coronary vasodilation induced by 17beta estradiol in ischemic heart failure. FASEB J 11: 793-799, 1997.
9. Hall JM, Caurse JF and Korach KS: The multifaceted mechanisms of estradiol and estrogen receptor signalling. J Biol Chem 76: 36869-36872, 2001. (Pubitemid 37384094)
10. Shao D, Berrodin TJ, Manas E, Hauze D, Powers R, Bapat A, Gonder D, Winneker RC and Frail DE: Identification of novel estrogen receptor alpha antagonists. J Steroid Biochem Mol Biol 88: 351-360, 2004.
11. Nilsson S, Makela S, Treuter E, Tujague M, Thomen J, Andersson G, Enmark E, Pettersson K, Warner M and Gustafsson JA: Mechanisms of estrogen action. Physiol Rev 4: 1535-1565, 2001.
12. McDonnel DP, Connor CE, Wijayaratna A, Chang CY and Norris TD: Definition of the molecular and cellular mechanisms underlying the tissue selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog Horm Res 57: 295-316, 2002.
13. Falkenstein E, Tillmann HC, Christ M, Feuring M and Wehling M: Multiple actions of steroid hormones - a focus on rapid, nongenomic effects Pharmacol Rev 52: 513-556, 2000.
14. Carmeci C, Thompson DA, Ring HZ, Francke U and Weigel RJ: Identification of a gene (GPR30) with homology to the G-protein coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45: 607-617, 1997.
15. O'Dowd BF, Nguyen T, Marchese A, Cheng R, Lynch KR, Heng HH, Kolakowski LF Jr and George SR: Discovery of three novel G-protein coupled recepror genes. Genomics 47: 310-313, 1998. (Pubitemid 28086858)
16. Owman C, Blay P, Nilsson C and Lolait SJ: Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem Biophys Res Commun 228: 285-292, 1996.
17. Takada Y, Kato C, Kondo S, Korenaga R and Ando J: Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem Biophys Res Commun 240: 737-741, 1997.
18. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J and Thomas P: Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148: 3236-3245, 2007. (Pubitemid 46997004)
19. Thomas P, Pang Y, Filardo EJ and Dong J: Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 624-632, 2005.
20. Filardo EJ and Thomas P: GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16: 362-367, 2005.
21. Revankar CM, Cimino DF, Sklar LA, Arterburn JB and Prossnitz ER: A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630, 2005.
22. Prossnitz ER, Oprea TI, Sklar LA and Arterburn JB: The ins and outs of GPR30: a transmembrane estrogen receptor. J Steroid Biochem Mol Biol 109: 350-353, 2008.
23. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI and Prossnitz ER: Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2: 207-212, 2006.
24. Deschamps AM and Murphy E: Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol 297: 1806-1813, 2009.
25. Bopassa JC, Eghbali M, Toro L and Stefani E: A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol 298: 16-23, 2010.
26. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, Gao X, Mueller-Guerre L, Marjon NA, Gut A, Minotti R, Meyer MR, Amann K, Ammann E, Perez-Dominguez A, Genoni M, Clegg DJ, Dun NJ, Resta TC, Prossnitz ER and Barton M: Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 104: 288-291, 2009.
27. Karteris E, Machado RJ, Chen J, Zervou S, Hillhouse EW and Randeva HS: Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex. Am J Physiol Endocrinol Metab 288: 1089-10100, 2005.
28. Bose AK, Mocanu MM, Carr RD, Brand CL and Yellon DM: Glucagon-like peptide 1 can directly protect theheart against ischaemia/reperfusion injury. Diabetes 54: 146-151, 2005.
29. + exchange inhibitor, on cardioprotective effect of ischaemic and angiotensin preconditioning. Mol Cell Biochem 214: 31-38, 2000.
30. Ogino H, Smolenski RT, Zych M, Seymour AM and Yacoub MH: Influence of preconditioning on rat heart subjected to prolonged cardioplegic arrest. Ann Thorac Surg 62: 469-474, 1996. (Pubitemid 26259690)
31. Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, Mocanu MM and Yellon DM: Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol 103: 274-284, 2008.
32. Bose AK, Mocanu MM, Carr RD and Yellon DM: Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway. Cardiovasc Drugs Ther 21: 253-256, 2007.
33. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K and Wehling M: Non genomic steroid action: controversies, questions and answers. Physiol Rev 83: 965-1016, 2003.
34. Watters JJ, Chun TY, Kim YN, Bertics PJ and Gorski J: Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol Endocrinol 14: 1872-1881, 2000.
35. Song RX, Santen RJ, Kumar R, Adam L, Jeng MH, Masamura S and Yue W: Adaptive mechanisms induced by long term estrogen deprivation in breast cancer cells. Mol Cell Endocrinol 193: 29-42, 2002. (Pubitemid 34823605)
36. Harlap S: The benefits and risks of hormone replacement therapy: an epidemiologic overview. Am J Obstet Gynecol 166: 1986-1992, 1992.
37. Colditz GA: Fat, estrogen, and the time frame for prevention of breast cancer. Epidemiology 3: 209-211, 1995.